121 related articles for article (PubMed ID: 2471908)
1. Recombinant human granulocyte-macrophage colony-stimulating factor plus the beam regimen instead of autologous bone marrow transplantation.
Fouillard L; Gorin NC; Laporte JP; Douay L; Isnard F; Najman A
Lancet; 1989 Jun; 1(8652):1460. PubMed ID: 2471908
[No Abstract] [Full Text] [Related]
2. BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy.
Jantunen E; Kuittinen T; Nousiainen T
Leuk Lymphoma; 2003 Jul; 44(7):1151-8. PubMed ID: 12916867
[TBL] [Abstract][Full Text] [Related]
3. GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen.
Laporte JP; Fouillard L; Douay L; Eugene-Jolchine I; Isnard F; Stachowiak J; Najman A; Gorin NC
Lancet; 1991 Sep; 338(8767):601-2. PubMed ID: 1679155
[TBL] [Abstract][Full Text] [Related]
4. [Autologous transplant with BEAM protocol in lymphoma].
Caballero D; Rubio V; Rifon J; Heras I; García-Sanz R; Vidriales B; Pérez-Simón JA; del Cañizo C; González M; León A; Jean-Paul E; Rocha E; Vicente V; San Miguel JF
Sangre (Barc); 1997 Apr; 42 Suppl 1():46-9. PubMed ID: 9381303
[No Abstract] [Full Text] [Related]
5. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
[TBL] [Abstract][Full Text] [Related]
6. Single-dose pegylated-filgrastim versus daily filgrastim after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: delayed platelets recovery?
Tendas A; Cupelli L; Bruno A; Niscola P; De Angelis V; Datturi T; Cantoni F; De Meis I; Dentamaro T; de Fabritiis P
Blood Transfus; 2012 Oct; 10(4):561-2. PubMed ID: 22395357
[No Abstract] [Full Text] [Related]
7. BEAM protocol and autologous bone marrow transplantation in first chemosensitive relapse of non-Hodgkin's lymphomas.
Colombat P; Biron P; Laporte JP; Cahn JY; Herve P; Gorin NC; Lamagnere JP; Philip T
Eur J Cancer; 1990; 26(7):858. PubMed ID: 2145921
[No Abstract] [Full Text] [Related]
8. Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma.
Cortelazzo S; Viero P; Bellavita P; Rossi A; Buelli M; Borleri GM; Marziali S; Bassan R; Comotti B; Rambaldi A
J Clin Oncol; 1995 Apr; 13(4):935-41. PubMed ID: 7535843
[TBL] [Abstract][Full Text] [Related]
9. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.
Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G;
Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180
[TBL] [Abstract][Full Text] [Related]
10. A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant.
Laporte JP; Yeshurun M; Fouillard L; Labopin M; Cailliot C; Lesage S; Isnard F; Najman A; Gorin NC
Leukemia; 2004 Oct; 18(10):1717-21. PubMed ID: 15295607
[TBL] [Abstract][Full Text] [Related]
11. Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
Vitolo U; Cortellazzo S; Liberati AM; Freilone R; Falda M; Bertini M; Botto B; Cinieri S; Levis A; Locatelli F; Lovisone E; Marmont F; Pizzuti M; Rossi A; Viero P; Barbui T; Grignani F; Resegotti L
J Clin Oncol; 1997 Feb; 15(2):491-8. PubMed ID: 9053470
[TBL] [Abstract][Full Text] [Related]
12. Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma.
Shimoni A; Zwas ST; Oksman Y; Hardan I; Shem-Tov N; Yerushalmi R; Avigdor A; Ben-Bassat I; Nagler A
Exp Hematol; 2007 Apr; 35(4):534-40. PubMed ID: 17379063
[TBL] [Abstract][Full Text] [Related]
13. Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high-grade lymphoma.
Laporte JP; Lesage S; Woler M; Parlier Y; Daguenel A; Najman A; Gorin NC
Eur J Haematol; 1994 Aug; 53(2):123-5. PubMed ID: 7522189
[No Abstract] [Full Text] [Related]
14. Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas.
Stahel RA; Jost LM; Honegger H; Betts E; Goebel ME; Nagler A
J Clin Oncol; 1997 May; 15(5):1730-5. PubMed ID: 9164179
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
Haas R; Hohaus S; Egerer G; Ehrhardt R; Witt B; Hunstein W
Bone Marrow Transplant; 1992 Jun; 9(6):459-65. PubMed ID: 1352717
[TBL] [Abstract][Full Text] [Related]
16. Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
Rifkin R; Spitzer G; Orloff G; Mandanas R; McGaughey D; Zhan F; Boehm KA; Asmar L; Beveridge R
Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):186-91. PubMed ID: 20511163
[TBL] [Abstract][Full Text] [Related]
17. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
[TBL] [Abstract][Full Text] [Related]
18. Immunomagnetic selection of CD34(+) cells carried out in cryopreserved cell concentrates from a paediatric patient affected with non-Hodgkin lymphoma.
Zinno F; Landi F; Aureli V; Cometa AM; Scerpa MC; Caniglia M; Pinto RM; Rana I; Balduino G; Miele MJ; Isacchi G
Transfus Med; 2010 Aug; 20(4):283-6. PubMed ID: 20136780
[No Abstract] [Full Text] [Related]
19. [What is your diagnosis? Neutropenic colitis (neutropenic typhlitis)].
Ernst S; Bühlmann M; Stucki A; Bükki J; Stanga Z
Praxis (Bern 1994); 2007 Jan; 96(4):99-100. PubMed ID: 17294584
[No Abstract] [Full Text] [Related]
20. Delayed neutrophil recovery after BEAM chemotherapy and autologous bone marrow transplantation for lymphoma is not associated with increased mortality from infection.
Khwaja A; Goldstone AH; Linch DC
Bone Marrow Transplant; 1995 Feb; 15(2):313-5. PubMed ID: 7773224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
